摘要
目的:检测弥漫大B细胞淋巴瘤(diffuse large B cell lymphoma,DLBCL)细胞中micro RNA-296-5P(mi RNA-296-5p)的表达水平,并研究干扰mi RNA-296-5p的表达对DLBCL细胞株DB的增殖、迁移及凋亡的影响。方法:应用人淋巴细胞分离液提取健康人外周血单个核细胞,实时荧光定量PCR检测单个核细胞与DLBCL-DB细胞mi RNA-296-5p的表达。利用mi RNA-296-5p inhibitor干扰DB细胞mi RNA-296-5p的表达,实时荧光定量PCR检测转染后mi RNA-296-5p的表达,并进一步用CCK-8法、Transwell法和Annexin V-FITC/PI双染法检测转染后细胞增殖、迁移和凋亡的变化。结果:mi RNA-296-5p在DLBCL细胞株DB中明显高表达,转染mi RNA-296-5p inhibitor后细胞的增殖和迁移能力明显受到抑制,而细胞凋亡没有明显改变。结论:mi RNA-296-5p的高表达可能与DLBCL的发生发展有关,可能成为DLBCL的预后评估指标之一。
Objective: To detect the expression of miRNA-296-5p in diffuse large B cell lymphoma (DLBCL) cells and study the proliferation, migration and apoptosis of DLBCL cells after interfering the expression of miRNA-296-5p. Methods: The expression of miRNA-296-5p in DLBCL cells line DB cells was detected by real-time quantitative reverse -transcription polymerase chain reaction (qRT-PCR). The possible roles of miRNA-296-5p in the biological and behavioral properties of DLBCL - DB cells were explored by transfection of miRNA-296-5p inhibitor for miRNA-296-5p knockdown, and detected by using CCK-8 method, Transwell method and Annexin V-FITC/PI. Results: miRNA-296- 5p was highly expressed in DLBCL - DB cells, and the inhibition of miRNA-296-Sp could induce suppression of cell proliferation and migration, but the cell apoptosis was not changed significantly. Conclusion:The high expression of miRNA-296-5p may relate with the occurence and developmentof DLBCL, which may be a new therapeutic target for DLBCL.
作者
刘小四
王馨辰
丁凯阳
伍权
LIU Xiao-Si, WANG Xin-Chen, DING Kai-Yang, WU Quan(Department of Hematology, Provincial Hospital Affiliated to Anhui Medical University, Hefei 230000, Anhui Province, China)
出处
《中国实验血液学杂志》
CAS
CSCD
北大核心
2018年第2期437-442,共6页
Journal of Experimental Hematology
基金
安徽省科技厅自然基金(1608085MH228)